These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37044284)

  • 1. Psychotic symptoms and neurocognition among patients with major depressive disorder: A chained mediation model of depressive symptoms and socio-occupational functioning.
    Zeng Y; Zhang F; Liu H; Li W; Ning Y; Zhou Y
    J Affect Disord; 2023 Jul; 332():194-200. PubMed ID: 37044284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediating effect of neurocognition between severity of symptoms and social-occupational function in anxious depression.
    Liu W; Zhou Y; Zheng W; Wang C; Zhan Y; Li H; Chen L; Zhao C; Ning Y
    J Affect Disord; 2019 Mar; 246():667-673. PubMed ID: 30611065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder.
    Lam RW; Iverson GL; Evans VC; Yatham LN; Stewart K; Tam EM; Axler A; Woo C
    J Affect Disord; 2016 Oct; 203():55-61. PubMed ID: 27280963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum lipid levels with psychotic symptoms in young, first-episode and drug naïve outpatients with major depressive disorder: A large-scale cross-sectional study.
    Yan L; Kang C; Wang X; Yang L; Zhao N; Zhang X
    Psychiatry Res; 2022 Nov; 317():114864. PubMed ID: 36179590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints.
    Mohn C; Rund BR
    BMC Psychiatry; 2016 Apr; 16():108. PubMed ID: 27095362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia.
    Quek YF; Yang Z; Dauwels J; Lee J
    Front Psychiatry; 2021; 12():648108. PubMed ID: 34381384
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence and risk factors of psychotic symptoms in middle-aged patients with first-episode drug-naïve major depressive disorder: A large-scale cross-sectional study.
    Liu S; Lin K; Zhang Y; Gao Y; Wang W; Du M; Jiang T; Zhou M; Zhang X
    J Affect Disord; 2023 Mar; 325():102-109. PubMed ID: 36623569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimensional approach to symptom factors of major depressive disorder in Koreans, using the Brief Psychiatric Rating Scale: the Clinical Research Center for Depression of South Korea study.
    Park SC; Jang EY; Kim D; Jun TY; Lee MS; Kim JM; Kim JB; Jo SJ; Park YC
    Kaohsiung J Med Sci; 2015 Jan; 31(1):47-54. PubMed ID: 25600920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative and disorganized symptoms mediate the relationship between verbal learning and global functioning in adolescents with early-onset psychosis.
    Smelror RE; Rund BR; Lonning V; Jørgensen KN; Wedervang-Resell K; Andreassen OA; Ueland T; Myhre AM; Agartz I
    Eur Child Adolesc Psychiatry; 2020 Dec; 29(12):1693-1703. PubMed ID: 32036438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.
    Ishak WW; Balayan K; Bresee C; Greenberg JM; Fakhry H; Christensen S; Rapaport MH
    Qual Life Res; 2013 Apr; 22(3):585-96. PubMed ID: 22544416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the BPRS-5 subscale of the psychotic depression assessment scale a reliable screening tool for psychotic depression?: Results from the CRESCEND study.
    Park SC; Østergaard SD; Choi J; Kim JM; Jun TY; Lee MS; Kim JB; Yim HW; Park YC
    J Affect Disord; 2015 Mar; 174():188-91. PubMed ID: 25506755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum lipid levels with psychotic symptoms in first-episode and drug naïve outpatients with major depressive disorder: a large-scale cross-sectional study.
    Wang X; Yang L; Liu J; Kang C; Zheng Y; Qiu S; Zhao Y; Goodman CB; Wu HE; Zhao N; Zhang X
    J Affect Disord; 2022 Jan; 297():321-326. PubMed ID: 34710503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotic symptoms in first-episode and drug naïve patients with major depressive disorder: Prevalence and related clinical factors.
    Shen Y; Wei Y; Yang XN; Zhang G; Du X; Jia Q; Zhu X; Ma Y; Lang X; Luo X; Zhang XY
    Depress Anxiety; 2020 Aug; 37(8):793-800. PubMed ID: 32383260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, clinical correlates and IQ of suicidal ideation in drug naïve Chinese Han patients with major depressive disorder.
    Li X; Liu H; Hou R; Baldwin DS; Li R; Cui K; Liu C; Sun Q; Wang G; Tan Q; Xu X; Zhao J; Ning Y; Sun X
    J Affect Disord; 2019 Apr; 248():59-64. PubMed ID: 30711870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Sánchez-Morla EM; Aparicio AI; López-Villarreal A; Martínez-Vizcaíno V; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2018 Mar; 229():177-185. PubMed ID: 29316520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder.
    Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P
    Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments.
    Lystad JU; Falkum E; Haaland VØ; Bull H; Evensen S; Bell MD; Ueland T
    Schizophr Res; 2016 Jan; 170(1):143-9. PubMed ID: 26692347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder.
    O'Reilly K; Donohoe G; Coyle C; O'Sullivan D; Rowe A; Losty M; McDonagh T; McGuinness L; Ennis Y; Watts E; Brennan L; Owens E; Davoren M; Mullaney R; Abidin Z; Kennedy HG
    BMC Psychiatry; 2015 Jul; 15():155. PubMed ID: 26159728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognition and Depressive Symptoms have Unique Pathways to Predicting Different Domains of Functioning in Major Depressive Disorder.
    Wood-Ross C; Tran T; Milanovic M; Jokic R; Milev R; Bowie CR
    Can J Psychiatry; 2023 Apr; 68(4):241-248. PubMed ID: 36411975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MATRICS Consensus Cognitive Battery (MCCB): performance and functional correlates.
    Lystad JU; Falkum E; Mohn C; Haaland VØ; Bull H; Evensen S; Rund BR; Ueland T
    Psychiatry Res; 2014 Dec; 220(3):1094-101. PubMed ID: 25242432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.